91 related articles for article (PubMed ID: 21868524)
21. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
22. High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Palmero A; Berger M; Venturi C; Ferrero I; Rustichelli D; Berta L; Frairia R; Madon E; Fagioli F
Oncol Rep; 2006 Jan; 15(1):267-73. PubMed ID: 16328067
[TBL] [Abstract][Full Text] [Related]
23. Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.
Sun Y; Zhang T; Gao P; Meng B; Gao Y; Wang X; Zhang J; Wang H; Wu X; Zheng W; Zhou G
Breast Cancer Res Treat; 2010 Jun; 121(3):591-9. PubMed ID: 19693666
[TBL] [Abstract][Full Text] [Related]
24. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
Chen F; Wang T; Wang J; Wang ZQ; Qian M
Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
[TBL] [Abstract][Full Text] [Related]
25. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
[TBL] [Abstract][Full Text] [Related]
26. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
28. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
29. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
30. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance in renal cell carcinoma by short hairpin RNA targeting MDR1 gene.
Hao YX; He ZW; Zhu JH; Shen Q; Sun JZ; DU N; Xiao WH
Chin Med J (Engl); 2012 Aug; 125(15):2741-5. PubMed ID: 22931984
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.
Susa M; Iyer AK; Ryu K; Choy E; Hornicek FJ; Mankin H; Milane L; Amiji MM; Duan Z
PLoS One; 2010 May; 5(5):e10764. PubMed ID: 20520719
[TBL] [Abstract][Full Text] [Related]
33. Targeting hedgehog-GLI-2 pathway in osteosarcoma.
Yang W; Liu X; Choy E; Mankin H; Hornicek FJ; Duan Z
J Orthop Res; 2013 Mar; 31(3):502-9. PubMed ID: 22968906
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study.
Yue B; Ma JF; Yao G; Yang MD; Cheng H; Liu GY
Eur Rev Med Pharmacol Sci; 2014; 18(12):1735-41. PubMed ID: 24992616
[TBL] [Abstract][Full Text] [Related]
35. 42- and 63-bp anti-MDR1-siRNAs bearing 2'-OMe modifications in nuclease-sensitive sites induce specific and potent gene silencing.
Gvozdeva OV; Dovydenko IS; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
FEBS Lett; 2014 Mar; 588(6):1037-43. PubMed ID: 24561194
[TBL] [Abstract][Full Text] [Related]
36. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.
Kun-Peng Z; Xiao-Long M; Chun-Lin Z
Int J Biol Sci; 2018; 14(3):321-330. PubMed ID: 29559849
[TBL] [Abstract][Full Text] [Related]
37. EIF5A2 is a novel chemoresistance gene in breast cancer.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
[TBL] [Abstract][Full Text] [Related]
38. Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.
Aliabadi HM; Maranchuk R; Kucharski C; Mahdipoor P; Hugh J; Uludağ H
J Control Release; 2013 Nov; 172(1):219-228. PubMed ID: 23994345
[TBL] [Abstract][Full Text] [Related]
39. Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells.
Xie X; Ye Z; Yang D; Tao H
Mol Med Rep; 2013 Jul; 8(1):168-72. PubMed ID: 23685757
[TBL] [Abstract][Full Text] [Related]
40. The depletion of interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells.
Shao N; Chen LH; Ye RY; Lin Y; Wang SM
Biochem Biophys Res Commun; 2013 Feb; 431(3):535-41. PubMed ID: 23321310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
